Restructuring and Related Costs - Summary of Restructuring and Related Costs (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Restructuring Costs and Asset Impairment Charges [Abstract] | ||||
| Clinical trial expense and other third-party costs for the deprioritization of the luvelta program | $ 201 | $ 13,006 | $ 243 | $ 17,261 |
| Severance and benefits expense | 0 | 3,862 | 0 | 12,372 |
| Contract termination and other restructuring costs | 0 | 1,554 | 0 | 9,832 |
| Total | $ 201 | $ 18,422 | $ 243 | $ 39,465 |